Logo image of HRZN

HORIZON TECHNOLOGY FINANCE C (HRZN) Stock Fundamental Analysis

NASDAQ:HRZN - Nasdaq - US44045A1025 - Common Stock - Currency: USD

9.82  0 (0%)

After market: 9.7504 -0.07 (-0.71%)

Fundamental Rating

3

HRZN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 225 industry peers in the Capital Markets industry. Both the profitability and financial health of HRZN have multiple concerns. HRZN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

HRZN had positive earnings in the past year.
In the past year HRZN had a positive cash flow from operations.
HRZN had positive earnings in 4 of the past 5 years.
HRZN had a negative operating cash flow in each of the past 5 years.
HRZN Yearly Net Income VS EBIT VS OCF VS FCFHRZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M -150M -200M

1.2 Ratios

HRZN has a Return On Assets of -0.49%. This is in the lower half of the industry: HRZN underperforms 79.45% of its industry peers.
HRZN has a Return On Equity of -1.13%. This is in the lower half of the industry: HRZN underperforms 78.08% of its industry peers.
Industry RankSector Rank
ROA -0.49%
ROE -1.13%
ROIC N/A
ROA(3y)2.01%
ROA(5y)2.65%
ROE(3y)4.22%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
HRZN Yearly ROA, ROE, ROICHRZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

HRZN's Gross Margin of 0.45% is on the low side compared to the rest of the industry. HRZN is outperformed by 75.80% of its industry peers.
The Profit Margin and Operating Margin are not available for HRZN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HRZN Yearly Profit, Operating, Gross MarginsHRZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, HRZN has more shares outstanding
Compared to 5 years ago, HRZN has more shares outstanding
HRZN has a worse debt/assets ratio than last year.
HRZN Yearly Shares OutstandingHRZN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
HRZN Yearly Total Debt VS Total AssetsHRZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.32, we must say that HRZN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.32, HRZN is doing worse than 73.97% of the companies in the same industry.
The Debt to FCF ratio of HRZN is 10.51, which is on the high side as it means it would take HRZN, 10.51 years of fcf income to pay off all of its debts.
HRZN has a Debt to FCF ratio (10.51) which is comparable to the rest of the industry.
HRZN has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
HRZN's Debt to Equity ratio of 1.06 is in line compared to the rest of the industry. HRZN outperforms 51.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 10.51
Altman-Z 0.32
ROIC/WACCN/A
WACCN/A
HRZN Yearly LT Debt VS Equity VS FCFHRZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 1.14 indicates that HRZN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.14, HRZN is in line with its industry, outperforming 51.14% of the companies in the same industry.
A Quick Ratio of 1.14 indicates that HRZN should not have too much problems paying its short term obligations.
HRZN's Quick ratio of 1.14 is in line compared to the rest of the industry. HRZN outperforms 51.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
HRZN Yearly Current Assets VS Current LiabilitesHRZN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2

3. Growth

3.1 Past

The earnings per share for HRZN have decreased strongly by -21.76% in the last year.
HRZN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.35% yearly.
HRZN shows a decrease in Revenue. In the last year, the revenue decreased by -0.57%.
The Revenue has been growing slightly by 2.97% on average over the past years.
EPS 1Y (TTM)-21.76%
EPS 3Y17.84%
EPS 5Y10.35%
EPS Q2Q%-39.62%
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y3.4%
Revenue growth 5Y2.97%
Sales Q2Q%-15.7%

3.2 Future

The Earnings Per Share is expected to decrease by -15.21% on average over the next years. This is quite bad
HRZN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.51% yearly.
EPS Next Y-28.91%
EPS Next 2Y-19.35%
EPS Next 3Y-15.21%
EPS Next 5YN/A
Revenue Next Year-10.67%
Revenue Next 2Y-2.02%
Revenue Next 3Y0.51%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HRZN Yearly Revenue VS EstimatesHRZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
HRZN Yearly EPS VS EstimatesHRZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.50, the valuation of HRZN can be described as very cheap.
90.87% of the companies in the same industry are more expensive than HRZN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 29.62, HRZN is valued rather cheaply.
HRZN is valuated cheaply with a Price/Forward Earnings ratio of 7.63.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HRZN indicates a rather cheap valuation: HRZN is cheaper than 89.04% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.70. HRZN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.5
Fwd PE 7.63
HRZN Price Earnings VS Forward Price EarningsHRZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

72.60% of the companies in the same industry are more expensive than HRZN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.48
EV/EBITDA N/A
HRZN Per share dataHRZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as HRZN's earnings are expected to decrease with -15.21% in the coming years.
PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2Y-19.35%
EPS Next 3Y-15.21%

6

5. Dividend

5.1 Amount

HRZN has a Yearly Dividend Yield of 11.74%, which is a nice return.
HRZN's Dividend Yield is a higher than the industry average which is at 10.21.
HRZN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 11.74%

5.2 History

The dividend of HRZN has a limited annual growth rate of 2.19%.
HRZN has paid a dividend for at least 10 years, which is a reliable track record.
HRZN has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)2.19%
Div Incr Years2
Div Non Decr Years6
HRZN Yearly Dividends per shareHRZN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

The earnings of HRZN are negative and hence is the payout ratio. HRZN will probably not be able to sustain this dividend level.
DP-1198.11%
EPS Next 2Y-19.35%
EPS Next 3Y-15.21%
HRZN Yearly Income VS Free CF VS DividendHRZN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M -150M -200M

HORIZON TECHNOLOGY FINANCE C

NASDAQ:HRZN (2/21/2025, 8:26:02 PM)

After market: 9.7504 -0.07 (-0.71%)

9.82

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-29 2024-10-29/amc
Earnings (Next)02-25 2025-02-25/amc
Inst Owners8.88%
Inst Owner Change-79.2%
Ins Owners1.34%
Ins Owner Change2.12%
Market Cap391.62M
Analysts50
Price Target9.1 (-7.33%)
Short Float %0.8%
Short Ratio0.75
Dividend
Industry RankSector Rank
Dividend Yield 11.74%
Yearly Dividend1.33
Dividend Growth(5Y)2.19%
DP-1198.11%
Div Incr Years2
Div Non Decr Years6
Ex-Date02-18 2025-02-18 (0.11)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.33%
Min EPS beat(2)-10.4%
Max EPS beat(2)-2.27%
EPS beat(4)0
Avg EPS beat(4)-3.92%
Min EPS beat(4)-10.4%
Max EPS beat(4)-0.02%
EPS beat(8)4
Avg EPS beat(8)6.68%
EPS beat(12)7
Avg EPS beat(12)5.7%
EPS beat(16)10
Avg EPS beat(16)4.39%
Revenue beat(2)0
Avg Revenue beat(2)-3.04%
Min Revenue beat(2)-5.53%
Max Revenue beat(2)-0.56%
Revenue beat(4)0
Avg Revenue beat(4)-2.64%
Min Revenue beat(4)-5.53%
Max Revenue beat(4)-0.56%
Revenue beat(8)3
Avg Revenue beat(8)-3.58%
Revenue beat(12)4
Avg Revenue beat(12)-7.26%
Revenue beat(16)7
Avg Revenue beat(16)-2.24%
PT rev (1m)-0.46%
PT rev (3m)-0.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.16%
EPS NY rev (1m)0.09%
EPS NY rev (3m)-2.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 6.5
Fwd PE 7.63
P/S 8.08
P/FCF 9.48
P/OCF 9.48
P/B 1.14
P/tB 1.14
EV/EBITDA N/A
EPS(TTM)1.51
EY15.38%
EPS(NY)1.29
Fwd EY13.11%
FCF(TTM)1.04
FCFY10.55%
OCF(TTM)1.04
OCFY10.55%
SpS1.22
BVpS8.59
TBVpS8.59
PEG (NY)N/A
PEG (5Y)0.63
Profitability
Industry RankSector Rank
ROA -0.49%
ROE -1.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.45%
FCFM 85.19%
ROA(3y)2.01%
ROA(5y)2.65%
ROE(3y)4.22%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 10.51
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z 0.32
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.76%
EPS 3Y17.84%
EPS 5Y10.35%
EPS Q2Q%-39.62%
EPS Next Y-28.91%
EPS Next 2Y-19.35%
EPS Next 3Y-15.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y3.4%
Revenue growth 5Y2.97%
Sales Q2Q%-15.7%
Revenue Next Year-10.67%
Revenue Next 2Y-2.02%
Revenue Next 3Y0.51%
Revenue Next 5YN/A
EBIT growth 1Y-6.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y125.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y125.31%
OCF growth 3YN/A
OCF growth 5YN/A